Modulation of Growth Factor Signaling by Gangliosides: Positive Or Negative?

Methods in Enzymology

Volumn 417, Issue , 2006, Pages 168-185

  Kaucic, Karen ^a   Liu, Yihui ^a   Ladisch, Stephan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GANGLIOSIDE; GLYCOSPHINGOLIPID; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; INSULIN RECEPTOR; PLATELET DERIVED GROWTH FACTOR; PROTEIN TYROSINE KINASE; SIALIC ACID;

CANCER CELL; CANCER GROWTH; CELL SURVIVAL; CELL TYPE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIPOGENESIS; NORMAL HUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

CARBOHYDRATE SEQUENCE; GANGLIOSIDES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; SIGNAL TRANSDUCTION;

EID: 33751240515     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(06)17013-5     Document Type: Review

References (35)

1. Alessandri G., Filippeschi S., Sinibaldi P., Mornet F., Passera P., Spreafico F., Cappa P.M., and Gullino P.M. Influence of gangliosides on primary and metastatic neoplastic growth in human and murine cells. Cancer Res. 47 (1987) 4243-4247
2. Alves F., Borchers U., Keim H., Fortte R., Olschimke J., Vogel W.F., Halfter H., and Tietze L.F. Inhibition of EGF-mediated receptor activity and cell proliferation by HK1-ceramide, a stable analog of the ganglioside GM3-lactone. Glycobiology 12 (2002) 517-522
3. Bergelson L.D., Dyatlovitskaya E.V., Klyuchareva T.E., Kryukova E.V., Lemenovskaya A.F., Matveeva V.A., and Sinitsyna E.V. The role of glycosphingolipids in natural immunity. Gangliosides modulate the cytotoxicity of natural killer cells. Eur. J. Immunol. 19 (1989) 1979-1983
4. Bremer E.G., Hakomori S., Bowen-Pope D.F., Raines E., and Ross R. Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. J. Biol. Chem. 259 (1984) 6818-6825
5. Bremer E.G., Schlessinger J., and Hakomori S. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J. Biol. Chem. 261 (1986) 2434-2440
6. Farooqui T., Kelley T., Coggeshall K.M., Rampersaud A.A., and Yates A.J. GM1 inhibits early signaling events mediated by PDGF receptor in cultured human glioma cells. Anticancer Res. 19 (1999) 5007-5013
7. Grayson G., and Ladisch S. Immunosuppression by human gangliosides. II. Carbohydrate structure and inhibition of human NK activity. Cell Immunol. 139 (1992) 18-29
8. Hakomori S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 56 (1996) 5309-5318
9. Hakomori S., Handa K., Iwabuchi K., Yamamura S., and Prinetti A. New insights in glycosphingolipid function: "glycosignaling domain," a cell surface assembly of glycosphingolipids with signal transducer molecules involved in cell adhesion coupled with signaling. Glycobiology 8 (1998) xi-xix
10. Hynds D.L., Summers M., Van Brocklyn J., O'Dorisio M.S., and Yates A.J. Gangliosides inhibit platelet-derived growth factor-stimulated growth, receptor phosphorylation, and dimerization in neuroblastoma SH-SY5Y cells. J. Neurochem. 65 (1995) 2251-2258
11. Iyer V.R., Eisen M.B., Ross D.T., Schuler G., Moore T., Lee J.C., Trent J.M., Staudt L.M., Hudson Jr. J., Boguski M.S., Lashkari D., Shalon D., Botstein D., and Brown P.O. The transcriptional program in the response of human fibroblasts to serum. Science 283 (1999) 83-87
12. Jo M., Stolz D.B., Esplen J.E., Dorko K., Michalopoulos G.K., and Strom S.C. Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells. J. Biol. Chem. 275 (2000) 8806-8811
13. Ladisch S., Gillard B., Wong C., and Ulsh L. Shedding and immunoregulatory activity of YAC-1 lymphoma cell gangliosides. Cancer Res. 43 (1983) 3808-3813
14. Ladisch S., Li R., and Olson E. Ceramide structure predicts tumor ganglioside immunosuppressive activity. Proc. Natl. Acad. Sci. USA 91 5 (1994) 1974-1978
15. Lang Z., Guerrera M., Li R., and Ladisch S. Ganglioside GD1a enhances VEGF-induced endothelial cell proliferation and migration. Biochem. Biophys. Res. Commun. 282 (2001) 1031-1037
16. Ledeen R.W., and Yu R.K. Gangliosides: Structure, isolation, and analysis. Methods Enzymol. 83 (1982) 139-191
17. Li R., Liu Y., and Ladisch S. Enhancement of epidermal growth factor signaling and activation of SRC kinase by gangliosides. J. Biol. Chem. 276 (2001) 42782-42792
18. Li R., Manela J., Kong Y., and Ladisch S. Cellular gangliosides promote growth factor-induced proliferation of fibroblasts. J. Biol. Chem. 275 (2000) 34213-34223
19. Liu Y., Li R., and Ladisch S. Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization. J. Biol. Chem. 279 (2004) 36481-36489
20. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
21. Lu P., and Sharom F.J. Immunosuppression by YAC-1 lymphoma: Role of shed gangliosides. Cell. Immunol. 173 (1996) 22-32
22. Manfredi M.G., Lim S., Claffey K.P., and Seyfried T.N. Gangliosides influence angiogenesis in an experimental mouse brain tumor. Cancer Res. 59 (1999) 5392-5397
23. Meuillet E.J., Mania-Farnell B., George D., Inokuchi J.I., and Bremer E.G. Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431. Exp. Cell Res. 256 (2000) 74-82
24. Miljan E.A., and Bremer E.G. Regulation of growth factor receptors by gangliosides. Sci. STKE 2002 (2002) RE15
25. Miljan E.A., Meuillet E.J., Mania-Farnell B., George D., Yamamoto H., Simon H.G., and Bremer E.G. Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides. J. Biol. Chem. 277 (2002) 10108-11013
26. Mirkin B.L., Clark S.H., and Zhang C. Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1A and GT1B. Cell Prolif. 35 (2002) 105-115
27. Nishio M., Tajima O., Furukawa K., Urano T., and Furukawa K. Over-expression of GM1 enhances cell proliferation with epidermal growth factor without affecting the receptor localization in the microdomain in PC12 cells. Int. J. Oncol. 26 (2005) 191-199
28. Rebbaa A., Hurh J., Yamamoto H., Kersey D.S., and Bremer E.G. Ganglioside GM3 inhibition of EGF receptor mediated signal transduction. Glycobiology 6 (1996) 399-406
29. Rusnati M., Urbinati C., Tanghetti E., Dell'Era P., Lortat-Jacob H., and Presta M. Cell membrane GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2. Proc. Natl. Acad. Sci. USA 99 (2002) 4367-4372
30. Smart E.J., Ying Y.S., Mineo C., and Anderson R.G. A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc. Natl. Acad. Sci. USA 92 (1995) 10104-10108
31. Sottocornola E., Berra B., and Colombo I. GM3 content modulates the EGF-activated p185c-neu levels, but not those of the constitutively activated oncoprotein p185neu. Biochim. Biophys. Acta. 1635 (2003) 55-66
32. Suarez Pestana E., Greiser U., Sanchez B., Fernandez L.E., Lage A., Perez R., and Bohmer F.D. Growth inhibition of human lung adenocarcinoma cells by antibodies against epidermal growth factor receptor and by ganglioside GM3: Involvement of receptor-directed protein tyrosine phosphatase(s). Br. J. Cancer 75 (1997) 213-220
33. van Echten G., and Sandhoff K. Ganglioside metabolism. Enzymology, topology, and regulation. J. Biol. Chem. 268 (1993) 5341-5344
34. Zeng G., Gao L., Birkle S., and Yu R.K. Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production. Cancer Res. 60 (2000) 6670-6676
35. Zurita A.R., Maccioni H.J., and Daniotti J.L. Modulation of epidermal growth factor receptor phosphorylation by endogenously expressed gangliosides. Biochem. J. 355 (2001) 465-472